The Prevalence of Polypharmacy and Potential Drug-Drug Interactions among Iranian Cancer Patients: Which Patients were at Risk?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Drug-Drug interactions (DDIs) are one of the considerable consequences of polypharmacy. Due to the influence of polypharmacy and drug interactions on cancer treatment and patients` health outcomes, this study aimed to determine the prevalence of polypharmacy and potential DDIs among adult cancer patients in Kerman province, southeast of Iran.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cancer Invest

Title: Cancer investigation

Publisher: Informa UK Limited

ISSN (Electronic): 1532-4192

ISSN (Print): 0735-7907

Publication date (Electronic): May 2022

Volume: 40

Issue: 5

Affiliations

[1 ] Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.

[2 ] Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.

[3 ] Hematology and Oncology Division, Department of Internal Medicine, Kerman University of Medical Sciences, Kerman, Iran.

[4 ] HIV/ST I Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

[5 ] Department of Traditional Medicine, School of Traditional Medicine, Kerman University of Medical Sciences, Kerman, Iran.

[6 ] Medical Education Leadership and Management Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Article

DOI: 10.1080/07357907.2022.2037139

PubMed ID: 35099344

SO-VID: f3fc6b11-1c73-4925-8246-04d3ce626545

History

Keywords: Iran,Polypharmacy,cancer,chemotherapy,potential drug interactions

Data availability:

Keywords: Iran, Polypharmacy, cancer, chemotherapy, potential drug interactions

Comments

Comment on this article

scite_

Cited by 1

Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital
Authors: Akash Agnihotri, Saravana Kumar Ramasubbu, Arkapal Bandyopadhyay …

See all cited by